Pharmacokinetics and safety of multiple oral doses of sustained-release 4-aminopyridine (fampridine-sr) in subjects with chronic, incomplete spinal cord injury 11A commercial party with a direct financial interest in the results of the research supporting this article has conferred or will confer a financial benefit on the author or 1 or more of the authors.-Reference-Cited by-同舟云学术

Pharmacokinetics and safety of multiple oral doses of sustained-release 4-aminopyridine (fampridine-sr) in subjects with chronic, incomplete spinal cord injury 11A commercial party with a direct financial interest in the results of the research supporting this article has conferred or will confer a financial benefit on the author or 1 or more of the authors.

Published:2004-01 Issue:1 Volume:85 Page:29-34
ISSN:0003-9993
Container-title:Archives of Physical Medicine and Rehabilitation
language:en
Short-container-title:Archives of Physical Medicine and Rehabilitation

Author:

Hayes Keith C,Potter Patrick J,Hsieh Jane T,Katz Mitchell A,Blight Andrew R,Cohen Ron

Publisher

Elsevier BV

Subject

Rehabilitation,Physical Therapy, Sports Therapy and Rehabilitation

Reference33 articles.

1. Spinal cord injury;J Spinal Cord Med,2000

2. Workforce participation survey of Canadians with spinal cord injury,2003

3. Randomized double-blind crossover trial of fampridine-SR (sustained release 4-aminopyridine) in patients with incomplete spinal cord injury;Potter;J Neurotrauma,1998

4. 4-Aminopyridine in chronic spinal cord injury;Hansebout;J Neurotrauma,1993

5. Sustained improvements in neurological function in spinal cord injured patients treated with oral 4-aminopyridine;Potter;Spinal Cord,1998

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. 4-aminopyridine improves evoked potentials and ambulation in the taiep rat: A model of hypomyelination with atrophy of basal ganglia and cerebellum;PLOS ONE;2024-03-01

2. Determination of five potential genotoxic impurities in dalfampridine using liquid chromatography;Journal of Pharmaceutical and Biomedical Analysis;2017-01

3. Fampridine and quality of life in individuals with multiple sclerosis;SpringerPlus;2016-07-13

4. Dalfampridine Improves Sensorimotor Function in Rats With Chronic Deficits After Middle Cerebral Artery Occlusion;Stroke;2013-07

5. Dalfampridine in patients with downbeat nystagmus—an observational study;Journal of Neurology;2013-04-16